Vanillin series electronic atomization liquid, preparation method and electronic atomization device

Abstract

The invention relates to vanillin series electronic atomization liquid, a preparation method and an electronic atomization device. The vanillin series electronic atomized liquid is prepared from the following components in parts by weight: 0 to 99.9979 parts of a solvent, 0.002 to 15 parts of sweetening agent molecules and 0.0001 to 20 parts of vanillin series nerve sweet sensing molecules. The vanillin series nerve sweet sensing molecules comprise ethyl vanillin, vanillin, isoeugenol, junifolene and eugenol. The invention further discloses a preparation method of the vanillin series nerve sweet sensing molecules. The vanillin series electronic atomized liquid provided by the invention not only contains conventional sweetening agent molecules, but also is added with vanillin series nerve sweet sense molecules, and under the combined action of the sweetening agent molecules and the vanillin series nerve sweet sense molecules, the electronic atomized liquid can present high sweetness after being atomized, and is comfortable in mouth feel and suitable for smoking.

Description

Technical Field

[0001] The present application relates to the field of electronic atomization technology, and in particular to a vanillin series electronic atomization liquid, a preparation method, and an electronic atomization device. Background Art

[0002] The mechanism of action of the electronic atomizer is to convert the atomized liquid into aerosol through the atomizer for human inhalation. Adding flavor molecules and sweetener molecules to the atomized liquid can achieve a rich taste and mouthfeel. Different types of sweetener molecules and their compounding methods and dosages will affect the performance of the flavor and thus change the feeling of people when inhaling. Therefore, the degree of consumer acceptance and favor of electronic atomizers depends on the formula of the atomized liquid.

[0003] Typical electronic atomization liquid usually contains glycosides, dipeptides, halogenated sucrose and other sweetener molecules commonly used in the beverage industry. These sweetener molecules can provide stronger sweetness with lower calories. However, unlike traditional beverages and foods, electronic atomization liquid enters the mouth in the form of aerosol after atomization. Compared with direct drinking, the selection and dosage of sweetener molecules have more requirements and challenges. The main reasons are: (1) Since the sweetener molecules in the atomized liquid still exist in the form of sol after entering the mouth with the aerosol, the contact with taste receptor cells is far less close than that of liquid media such as beverages. Therefore, atomization liquid with higher concentration and sweetness is required to generate aerosol with a more suitable sweetness for inhalation. (2) Some high-sweetness dipeptide sweetener molecules will produce odor during high-temperature atomization. If the sweetness of the aerosol is increased by increasing the concentration of sweetener molecules alone, it is easy to cause the electronic atomization device to become blocked and the sweetness to be seriously distorted, thus affecting the overall taste. Summary of the invention

[0004] Based on this, it is necessary to provide a vanillin series electronic atomization liquid, a preparation method, and an electronic atomization device that can improve the smoking taste.

[0005] On the one hand, the present application provides a vanillin series electronic atomization liquid, which comprises the following components in parts by weight:

[0006] 0 to 99.9979 parts of solvent,

[0007] 0.002 to 15 parts of sweetener molecules, and

[0008] 0.0001 to 20 parts of vanillin series neurosweetness molecules.

[0009] The vanillin series neurosweetness molecules include ethyl vanillin, vanillin, isoeugenol, cadinene and eugenol.

[0010] In some embodiments, per 100 parts by weight, the following components satisfy the following conditions:

[0011] 74 to 82 parts of the solvent,

[0012] 8 to 15 parts of the sweetener molecule, and

[0013] The vanillin series neurosweetness molecules are 9 to 12 parts.

[0014] In some embodiments, the vanillin series neurosweetness molecules also include 2-ethoxy-5-(1-propenyl)phenol, asarone, cubebene, terpinolene, myrcene, safrole, vetiverol, benzyl alcohol, methyl salicylate, γ-undecalactone, citral, ionone, dodecanal, octanal, jasmonate, tetradic acid, 2-hexanone, 2-heptanone, 1,8-cineole, cymene, nonanol, heptanol, terpinene, terpinene-4-ol, and 2-phenylethanol. One or more combinations thereof.

[0015] In some embodiments, the solvent includes a combination of one or more of water, ethanol, ethylene glycol, propanol, propylene glycol, glycerol, butanol, butylene glycol, butanetriol, benzyl alcohol, triethyl citrate, triacetin and caprylic decanoic acid glyceride.

[0016] In some embodiments, the sweetener molecules include one or more combinations of neotame, advantame, sucralose, acesulfame potassium, glucosyl steviol glycosides, aspartame, hesperidin dihydrochalcone, neohesperidin dihydrochalcone and naringin dihydrochalcone.

[0017] In some of the embodiments, the components of the vanillin series electronic atomization liquid also include one or more of flavors, nicotine salts and cooling agents.

[0018] In some embodiments, the flavor includes one or more combinations of strawberry flavor, watermelon flavor, lemon flavor, peach flavor, mango flavor, papaya flavor, orange flavor, grape flavor, lychee flavor, dragon fruit flavor, grapefruit flavor, apple flavor, banana flavor and coconut flavor.

[0019] In some embodiments, the nicotine salt comprises a combination of one or more of nicotine benzoate, nicotine levulinate, nicotine tartrate, nicotine citrate, nicotine acetate and nicotine oxalate.

[0020] In some embodiments, the cooling agent includes a combination of one or more of WS-3, WS-5, WS-12, WS-14, WS-23, WS-25, WS-27, menthol, menthyl ether and menthyl ester.

[0021] On the other hand, the present application also provides a method for preparing the vanillin series electronic atomization liquid as described in any of the above embodiments, comprising the following steps:

[0022] The components contained in the vanillin series electronic atomization liquid are mixed according to proportion.

[0023] On the other hand, the present application also provides an electronic atomization device, comprising the vanillin series electronic atomization liquid described in any of the above embodiments.

[0024] The vanillin series electronic atomization liquid provided in the present application not only contains conventional sweetener molecules, but also adds vanillin series neurosweetness molecules. Under the joint action of the sweetener molecules and the vanillin series neurosweetness molecules, the electronic atomization liquid can present a high sweetness after atomization, and has a comfortable taste and is suitable for inhalation. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 Schematic diagram showing the comparison of the mechanism by which high sweetness is achieved through the joint action of neurosweetness molecules and sweetener molecules, and the mechanism by which high sweetness is achieved only by increasing the concentration of sweetener molecules. DETAILED DESCRIPTION

[0026] For ease of understanding of the application, the application is described more fully below in conjunction with embodiments. The application can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the application more thorough and comprehensive.

[0027] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those skilled in the art to which the present application belongs. The terms used herein in the specification of the present application are only for the purpose of describing specific embodiments and are not intended to limit the present application. The term "and / or" used herein includes any and all combinations of one or more of the related listed items.

[0028] The terms "first", "second", "third", "fourth", etc. (if any) used in this application are used to distinguish similar objects and are only used for descriptive purposes, and are not necessarily used to describe a specific order or sequence. They cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" or "second" may explicitly or implicitly include at least one of the features. In the description of this application, the meaning of "multiple" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined.

[0029] Where “including,” “having,” and “comprising” are used herein, it is intended to cover a non-exclusive inclusion, and another component may also be added unless explicit limiting terms such as “only,” “consisting of,” etc. are used.

[0030] The words "optionally", "preferably", "more preferably", etc. in this application refer to embodiments of the present invention that may provide certain beneficial effects in certain circumstances. However, other embodiments may also be optional or preferred under the same or other circumstances. In addition, the statement of one or more preferred embodiments does not imply that other embodiments are not applicable, nor is it intended to exclude other embodiments from the scope of this application.

[0031] When a numerical range is disclosed in this application, the above range is considered to be continuous and includes the minimum and maximum values ​​of the range, as well as every value between such minimum and maximum values. Further, when a range refers to an integer, every integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be combined. In other words, unless otherwise indicated, all ranges disclosed in this application should be understood to include any and all subranges included therein.

[0032] Unless mentioned to the contrary, terms in the singular may include plural forms and should not be construed as being one in number.

[0033] In the present application, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0034] The inventors have found that although adding sweetener molecules to the atomized liquid can bring a richer smoking experience, there are many technical defects in simply increasing the concentration of sweetener molecules in the atomized liquid to increase the sweetness of the aerosol. The main reason is that for common sweetener molecules such as glycosides, dipeptides, and halogenated sucrose, structural changes will occur during the high-temperature atomization process after increasing the concentration, resulting in serious deformation of the sweetness, which in turn affects the overall taste. Moreover, high-concentration sweetener molecules will accumulate on the heating element to form carbon deposits during the atomization process, which will have serious adverse effects on the taste and life of the electronic atomization device. In addition, with the upgrading of the consumer market, the demand for diversified sweet tastes has gradually increased, and a single sweet taste can no longer meet the needs of consumers.

[0035] like Figure 1As shown, in order to solve the above problems, the inventors found that the sweetness and taste after inhalation can be improved based on the synergistic stimulation of taste and smell. The main mechanism of the above method is that the aerosol generated by the electronic atomization device will quickly fill the oral cavity, nasal cavity and throat cavity after being inhaled, and will produce taste and olfactory stimulation at the same time. The special flavor carrier gas of the aerosol provides a special advantage for the generation of sweetness, that is, the "taste-olfactory linkage" mechanism is used to enhance the neural sweetness. Taste is a near-sense stimulation produced by the contact between taste bud cells and substances, which can be mainly divided into sweet, salty, bitter, sour and fresh. Compared with taste, smell is a long-distance remote stimulation acting on the olfactory nervous system and the nasal trigeminal nervous system. Due to the high overlap of the distribution positions of olfactory receptor cells and taste receptor cells, the sensory stimulation of humans after tasting a certain substance is often the result of the joint participation of two sensory systems, namely taste and smell. Smell and taste are integrated and interact with each other during the perception process. For example, people with anosmia can only distinguish weak salty, sour and bitter tastes with their tongues, and it becomes very difficult to distinguish sweetness and umami, and they cannot distinguish fragrance at all. For electronic atomization devices, the aerosols they produce will quickly fill the mouth, nose and throat after being inhaled, and these parts will produce taste and smell stimulation at the same time. This determines that compared with beverages and foods, electronic atomization device aerosols can better utilize the "taste-smell linkage" mechanism to achieve a better sweetness experience.

[0036] Specifically, in the present application, the inventors added neurosweetness molecules into the electronic atomization liquid so that low-concentration sweetener molecules can produce a sweetness sensation far higher than their own. This not only avoids the burning and taste distortion caused by the use of high-concentration sweetener molecules, but also makes the sweetness more three-dimensional.

[0037] On the one hand, the present application provides a vanillin series electronic atomization liquid, which comprises the following components in parts by weight:

[0038] 0 to 99.9979 parts of solvent,

[0039] 0.002 to 15 parts of sweetener molecules, and

[0040] 0.0001 to 20 parts of vanillin series neurosweetness molecules.

[0041] The vanillin series of neurosweet molecules include ethyl vanillin, vanillin, isoeugenol, cadinene and eugenol.

[0042] The vanillin series electronic atomization liquid provided in the above embodiment can make full use of the "taste-olfactory linkage" mechanism to achieve a better sweetness experience. The main reason is that in the electronic atomization liquid, in addition to the conventionally added sweetener molecules, vanillin series neural sweetness molecules are also added. The addition of vanillin series neural sweetness molecules simulates the aroma feeling of eating sweet dairy products, and can cause all olfactory sensory conditioned reflexes except taste buds on the basis of high-sweetness sweeteners, so that the simple taste bud stimulation sweetness becomes more similar to the comprehensive sweetness brought by milk, chocolate, ice cream or other dairy products, while suppressing the harshness that may be produced by artificial sweeteners. The two are matched by specific weight parts, and a more three-dimensional and sweet taste can be produced after inhalation, and its sweetness taste is more comfortable than the sweetness produced by simply using high-concentration sweetener molecules.

[0043] It can be understood that the weight parts described in the present application refer to the weight proportions of each component in the vanillin series electronic atomization liquid. 1 weight part can be, for example but not limited to, 1 mg, 1 g, 1 kg, etc.

[0044] Furthermore, in the present application, the vanillin series neurosweetness molecules themselves do not have sweetness, and the sweetener molecules and the vanillin series neurosweetness molecules need to be matched in the above-mentioned specific weight ratio to obtain an electronic atomization liquid with a high sweet taste, high atomization fineness, and strong salivation. If the amount of sweetener molecules is too much and the amount of vanillin series neurosweetness molecules is too little, although a higher sweetness can be produced, it will cause serious problems such as burning and carbon deposition, and the sweetness will decay rapidly with the increase in the number of puffs. If the amount of vanillin series neurosweetness molecules used is too much and the amount of sweetener molecules used is too little, the sweetness will be lower and the sweetness will spread slowly.

[0045] In some of the embodiments, the following components satisfy the following conditions per 100 parts by weight:

[0046] 74 to 82 parts of solvent,

[0047] 8 to 15 parts of sweetener molecules, and

[0048] 9 to 12 parts of vanillin series neurosweetness molecules.

[0049] By using the above-mentioned preferred weight range of each component, it can further ensure that the vanillin series electronic atomization liquid can bring a more three-dimensional high sweetness after being atomized by the electronic atomization device, and will not be burnt or deformed in taste during the atomization process. At the same time, it can also bring a better sweet taste and high sweetness during the long-term high-temperature atomization process, with high atomization fineness, good sweet taste, strong salivation, and appropriate and long-lasting sweetness and sweetness release rate.

[0050] In some embodiments, the vanillin series neurosweetness molecules also include 2-ethoxy-5-(1-propenyl)phenol, asarone, cubeb, terpinolene, myrcene, safrole, vetiverol, benzyl alcohol, methyl salicylate, γ-undecalactone, citral, ionone, dodecanal, octanal, jasmonal, tetradecanoic acid, 2-hexanone, 2-heptanone, 1,8-cineole, cymene, nonanol, heptanol, terpinene, terpinene-4-ol, and 2-phenylethanol. In the vanillin series electronic atomization liquid, adding the above vanillin series neurosweetness molecules can further enhance the sweet experience.

[0051] In some embodiments, the solvent includes a combination of one or more of water, ethanol, ethylene glycol, propanol, propylene glycol, glycerol, butanol, butylene glycol, butanetriol, benzyl alcohol, triethyl citrate, triacetin and caprylic acid glyceride. In the electronic atomization liquid, the above compounds are used as solvents, which have good solubility for sweetener molecules, vanillin series neurosweetness molecules, and other components, ensuring that the various substances in the liquid of the vanillin series electronic atomization liquid are fully dissolved and evenly mixed, and are conducive to improving the atomization effect.

[0052] In some embodiments, the sweetener molecules include one or more combinations of neotame, advantame, sucralose, acesulfame potassium, glucosyl steviol glycosides, aspartame, hesperidin dihydrochalcone, neohesperidin dihydrochalcone and naringin dihydrochalcone. The use of the above sweetener molecules can make the electronic atomization liquid have a comfortable sweetness feeling, and can produce a better sweet taste when matched with the vanillin series neurosweetness molecules specified in the present application.

[0053] In some of the embodiments, the components of the vanillin series electronic atomization liquid also include one or more of flavors, nicotine salts and cooling agents.

[0054] In some embodiments, the flavor includes a combination of one or more of strawberry flavor, watermelon flavor, lemon flavor, peach flavor, mango flavor, papaya flavor, orange flavor, grape flavor, lychee flavor, pitaya flavor, grapefruit flavor, apple flavor, banana flavor and coconut flavor. The aroma of the vanillin series electronic atomization liquid can be further increased by adding the above flavors. It can be understood that the chemical composition of the flavor may contain the chemical composition of the above-mentioned vanillin series neurosweetness molecules. When calculating the added amount of the vanillin series neurosweetness molecules, they should be combined and calculated so that the weight of the vanillin series neurosweetness molecules meets their weight proportion in the vanillin series electronic atomization liquid.

[0055] In some embodiments, the nicotine salt includes a combination of one or more of nicotine benzoate, nicotine levulinate, nicotine tartrate, nicotine citrate, nicotine acetate, and nicotine oxalate. By adding the above nicotine salts, the excitement after inhaling the electronic atomization liquid can be appropriately increased, further enhancing the inhalation experience.

[0056] In some embodiments, the cooling agent includes one or more combinations of WS-3, WS-5, WS-12, WS-14, WS-23, WS-25, WS-27, menthol, menthyl ether and menthyl ester. By adding the above cooling agents, a refreshing mouthfeel can be produced after inhalation.

[0057] On the other hand, the present application also provides a method for preparing a vanillin series electronic atomization liquid as in any of the above embodiments, comprising the following steps:

[0058] The components contained in the vanillin series electronic atomization liquid are mixed according to proportion.

[0059] On the other hand, the present application also provides an electronic atomization device, comprising the vanillin series electronic atomization liquid in any of the above embodiments.

[0060] The following are specific embodiments.

[0061] Example 1

[0062] A vanillin series electronic atomization liquid comprises 81.43 parts of a solvent, 8 parts of a sweetener molecule, and 10.57 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0063] The solvent is: 41.43 parts of propylene glycol and 40 parts of glycerol.

[0064] The sweetener molecules are: 2 parts of neotame, 1 part of advantame, 1 part of sucralose, 3 parts of glucosyl steviol glycosides, and 1 part of neohesperidin dihydrochalcone.

[0065] The neurosweetness molecules of the vanillin series are: 1.14 parts of ethyl vanillin, 0.84 parts of isoeugenol, 0.67 parts of asarone, 0.79 parts of vanillin, 0.67 parts of cadinene, 0.84 parts of eugenol, 0.58 parts of cubebene, 0.78 parts of terpinolene, 0.66 parts of myrcene, 0.69 parts of safrole, 0.55 parts of vetiverol, 0.47 parts of benzyl alcohol, 0.14 parts of methyl salicylate, 0.27 parts of γ-undecalactone, 0.15 parts of citral. , 0.13 parts of ionone, 0.1 parts of dodecanal, 0.07 parts of octanal, 0.13 parts of jasminaldehyde, 0.04 parts of tetradecanoic acid, 0.05 parts of 2-hexanone, 0.03 parts of 2-heptanone, 0.04 parts of 1,8-cineole, 0.07 parts of cymene, 0.03 parts of nonanol, 0.04 parts of heptanol, 0.02 parts of terpinene, 0.02 parts of terpinene-4-ol, 0.03 parts of 2-phenylethanol, and 0.53 parts of 2-ethoxy-5-(1-propenyl)phenol.

[0066] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0067] Example 2

[0068] A vanillin series electronic atomization liquid comprises 80.02 parts of a solvent, 10 parts of a sweetener molecule, and 9.98 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0069] The solvent is: 40.02 parts of propylene glycol and 40 parts of glycerol.

[0070] The sweetener molecules are: 1 part of neotame, 1 part of advantame, 1 part of sucralose, 5 parts of glucosyl steviol glycosides, and 2 parts of neohesperidin dihydrochalcone.

[0071] The vanillin series of neurosweet molecules are: 1.22 parts of ethyl vanillin, 0.87 parts of isoeugenol, 0.99 parts of asarone, 0.71 parts of vanillin, 1 part of cadinene, 0.6 parts of eugenol, 0.49 parts of cubebene, 0.58 parts of terpinolene, 0.71 parts of myrcene, 0.52 parts of safrole, 0.47 parts of vetiverol, 0.38 parts of benzyl alcohol, 0.25 parts of methyl salicylate, 0.22 parts of γ-undecalactone , 0.19 parts of citral, 0.08 parts of ionone, 0.1 parts of dodecanal, 0.13 parts of octanal, 0.11 parts of jasminoides, 0.06 parts of tetradecanoic acid, 0.04 parts of 2-hexanone, 0.06 parts of 2-heptanone, 0.05 parts of 1,8-cineole, 0.03 parts of cymene, 0.05 parts of nonanol, 0.02 parts of heptanol, 0.02 parts of terpinene, 0.01 parts of terpinene-4-ol, and 0.02 parts of 2-phenylethanol.

[0072] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0073] Example 3

[0074] A vanillin series electronic atomization liquid comprises 74.57 parts of a solvent, 14 parts of a sweetener molecule, and 11.43 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0075] The solvent is: 34.57 parts of propylene glycol and 40 parts of glycerol.

[0076] The sweetener molecules are: 2 parts of neotame, 1 part of advantame, 2 parts of sucralose, 5 parts of glucosyl steviol glycoside, and 4 parts of neohesperidin dihydrochalcone.

[0077] The vanillin series of neurosweet molecules are: 0.97 parts of ethyl vanillin, 1.19 parts of isoeugenol, 1.18 parts of asarone, 1.1 parts of vanillin, 0.63 parts of cadinene, 0.48 parts of eugenol, 0.82 parts of cubebene, 0.87 parts of terpinolene, 0.79 parts of myrcene, 0.59 parts of safrole, 0.64 parts of vetiverol, 0.72 parts of benzyl alcohol, 0.24 parts of methyl salicylate, 0.26 parts of γ-undecene Ester, 0.13 parts of citral, 0.08 parts of ionone, 0.11 parts of dodecanal, 0.07 parts of octanal, 0.12 parts of jasminoids, 0.07 parts of tetradecanoic acid, 0.04 parts of 2-hexanone, 0.07 parts of 2-heptanone, 0.04 parts of 1,8-cineole, 0.06 parts of cymene, 0.07 parts of nonanol, 0.04 parts of heptanol, 0.02 parts of terpinene, 0.02 parts of terpinene-4-ol, and 0.01 parts of 2-phenylethanol.

[0078] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0079] Example 4

[0080] A vanillin series electronic atomization liquid comprises 89.998 parts of a solvent, 0.002 parts of a sweetener molecule, and 10 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0081] Among them, the solvent is: 39.998 parts of propylene glycol, 10 parts of glycerol, 5 parts of ethanol, 5 parts of ethylene glycol, 5 parts of water, 5 parts of propanol, 5 parts of butanol, 5 parts of butylene glycol, 5 parts of butanetriol, 1 part of benzyl alcohol, 1 part of triethyl citrate, 1 part of triacetin, and 2 parts of caprylic decanoic acid glyceride.

[0082] The sweetener molecules are: 0.001 parts of neotame and 0.001 parts of adventitium.

[0083] The vanillin series of neurosweet molecules are: 2 parts of ethyl vanillin, 2 parts of vanillin, 2 parts of isoeugenol, 2 parts of cadinene, and 2 parts of eugenol.

[0084] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0085] Example 5

[0086] A vanillin series electronic atomization liquid comprises 75 parts of a solvent, 15 parts of a sweetener molecule, and 10 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0087] The solvent is: 30 parts of propylene glycol, 30 parts of glycerol, 5 parts of ethanol, 5 parts of water, and 5 parts of butylene glycol.

[0088] The sweetener molecules are: 2 parts of neotame, 2 parts of advantame, 2 parts of glucosyl stevioside, 2 parts of neohesperidin dihydrochalcone, 1 part of acesulfame potassium, 2 parts of hesperidin dihydrochalcone, 1 part of naringin dihydrochalcone, 1 part of aspartame, and 2 parts of sucralose.

[0089] The vanillin series of neurosweet molecules are: 2 parts of ethyl vanillin, 2 parts of vanillin, 2 parts of isoeugenol, 2 parts of cadinene, and 2 parts of eugenol.

[0090] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0091] Example 6

[0092] A vanillin series electronic atomization liquid comprises 73 parts of a solvent, 7 parts of a sweetener molecule, and 20 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0093] The solvent is: 30 parts of propylene glycol, 30 parts of glycerol, 5 parts of ethylene glycol, 5 parts of propanol, and 3 parts of butanol.

[0094] The sweetener molecules are: 2 parts of neotame, 1 part of glucosyl stevioside, 1 part of neohesperidin dihydrochalcone, 1 part of hesperidin dihydrochalcone, 1 part of naringin dihydrochalcone, and 1 part of sucralose.

[0095] The vanillin series of neurosweet molecules are: 2 parts of ethyl vanillin, 2 parts of vanillin, 2 parts of isoeugenol, 2 parts of cadinene, 2 parts of eugenol, 2 parts of vetiverol, 2 parts of benzyl alcohol, 2 parts of methyl salicylate, 2 parts of γ-undecalactone, and 2 parts of citral.

[0096] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0097] Comparative Example 1

[0098] Comparative Example 1 is a comparative example of Example 1, except that the content of sweetener molecules is the same, but vanillin series neurosweetness molecules are not included. Specifically:

[0099] A vanillin series electronic atomization liquid comprises 92 parts of a solvent, 8 parts of a sweetener molecule, and no vanillin series neurosweetness molecule based on 100 parts by weight.

[0100] The solvent is: 52 parts of propylene glycol and 40 parts of glycerol.

[0101] The sweetener molecules are: 2 parts of neotame, 1 part of advantame, 1 part of sucralose, 3 parts of glucosyl steviol glycosides, and 1 part of neomethyl hesperidin dihydrochalcone.

[0102] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0103] Comparative Example 2

[0104] Comparative Example 2 is a comparative example of Example 1, except that the content of sweetener molecules is twice that of Example 1, but vanillin series neurosweetness molecules are not included. Specifically:

[0105] A vanillin series electronic atomization liquid comprises 84 parts of a solvent, 16 parts of a sweetener molecule, and no vanillin series neurosweetness molecule based on 100 parts by weight.

[0106] The solvent is: 44 parts of propylene glycol and 40 parts of glycerol.

[0107] The sweetener molecules are: 4 parts of neotame, 2 parts of advantame, 2 parts of sucralose, 6 parts of glucosyl steviol glycosides, and 2 parts of neohesperidin dihydrochalcone.

[0108] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0109] Comparative Example 3

[0110] Comparative Example 3 is a comparative example of Example 2, except that the content of sweetener molecules is the same, but vanillin series neurosweetness molecules are not included. Specifically:

[0111] A vanillin series electronic atomization liquid comprises 90 parts of a solvent, 10 parts of a sweetener molecule, and no vanillin series neurosweetness molecule based on 100 parts by weight.

[0112] The solvent is 50 parts of propylene glycol and 40 parts of glycerol.

[0113] The sweetener molecules are: 1 part of neotame, 1 part of adventitium, 1 part of sucralose, 5 parts of glucosyl steviol glycosides, and 2 parts of neohesperidin dihydrochalcone.

[0114] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0115] Comparative Example 4

[0116] Comparative Example 4 is a comparative example of Example 2, except that the content of sweetener molecules is twice that of Example 2, but vanillin series neurosweetness molecules are not included. Specifically:

[0117] A vanillin series electronic atomization liquid comprises 80 parts of a solvent, 20 parts of a sweetener molecule, and no vanillin series neurosweetness molecule based on 100 parts by weight.

[0118] The solvent is: 40 parts of propylene glycol and 40 parts of glycerol.

[0119] The sweetener molecules are: 2 parts of neotame, 2 parts of advantame, 2 parts of sucralose, 10 parts of glucosyl steviol glycoside, and 4 parts of neohesperidin dihydrochalcone.

[0120] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0121] Comparative Example 5

[0122] Comparative Example 5 is a comparative example of Example 3, except that the content of sweetener molecules is the same, but vanillin series neurosweetness molecules are not included. Specifically:

[0123] A vanillin series electronic atomization liquid comprises 86 parts of a solvent, 14 parts of a sweetener molecule, and no vanillin series neurosweetness molecule based on 100 parts by weight.

[0124] The solvent is: 46 parts of propylene glycol and 40 parts of glycerol.

[0125] The sweetener molecules are: 2 parts of neotame, 1 part of advantame, 2 parts of sucralose, 5 parts of glucosyl steviol glycoside, and 4 parts of neohesperidin dihydrochalcone.

[0126] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0127] Comparative Example 6

[0128] Comparative Example 6 is a comparative example of Example 3, except that the content of sweetener molecules is twice that of Example 3, but vanillin series neurosweetness molecules are not included. Specifically:

[0129] A vanillin series electronic atomization liquid comprises 72 parts of a solvent, 28 parts of a sweetener molecule, and no vanillin series neurosweetness molecule based on 100 parts by weight.

[0130] The solvent is: 32 parts of propylene glycol and 40 parts of glycerol.

[0131] The sweetener molecules are: 4 parts of neotame, 2 parts of edvantame, 4 parts of sucralose, 10 parts of glucosyl steviol glycoside, and 8 parts of neohesperidin dihydrochalcone.

[0132] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0133] Comparative Example 7

[0134] Comparative Example 7 is a comparative example of Example 4, except that the content of vanillin series neurosweetness molecules is the same, but the content of sweetener molecules is too low. Specifically:

[0135] A vanillin series electronic atomization liquid comprises 89.999 parts of a solvent, 0.001 parts of a sweetener molecule, and 10 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0136] Among them, the solvent is: 39.999 parts of propylene glycol, 10 parts of glycerol, 5 parts of ethanol, 5 parts of ethylene glycol, 5 parts of water, 5 parts of propanol, 5 parts of butanol, 5 parts of butylene glycol, 5 parts of butanetriol, 1 part of benzyl alcohol, 1 part of triethyl citrate, 1 part of triacetin, and 2 parts of caprylic decanoic acid glyceride.

[0137] The sweetener molecule is: 0.001 part of neotame.

[0138] The vanillin series of neurosweet molecules are: 2 parts of ethyl vanillin, 2 parts of vanillin, 2 parts of isoeugenol, 2 parts of cadinene, and 2 parts of eugenol.

[0139] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0140] Comparative Example 8

[0141] Comparative Example 8 is a comparative example of Example 5, except that the content of vanillin series neurosweetness molecules is the same, but the content of sweetener molecules is too high. Specifically:

[0142] A vanillin series electronic atomization liquid comprises 74 parts of a solvent, 16 parts of a sweetener molecule, and 10 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0143] The solvent is: 30 parts of propylene glycol, 30 parts of glycerol, 4 parts of ethanol, 5 parts of water, and 5 parts of butylene glycol.

[0144] The sweetener molecules are: 3 parts of neotame, 2 parts of advantame, 2 parts of glucosyl stevioside, 2 parts of neohesperidin dihydrochalcone, 1 part of acesulfame potassium, 2 parts of hesperidin dihydrochalcone, 1 part of naringin dihydrochalcone, 1 part of aspartame, and 2 parts of sucralose.

[0145] The vanillin series of neurosweet molecules are: 2 parts of ethyl vanillin, 2 parts of vanillin, 2 parts of isoeugenol, 2 parts of cadinene, and 2 parts of eugenol.

[0146] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation.

[0147] Comparative Example 9

[0148] Comparative Example 9 is a comparative example of Example 6, except that the content of sweetener molecules is the same, but the content of vanillin series neurosweetness molecules is too high. Specifically:

[0149] A vanillin series electronic atomization liquid comprises 72 parts of a solvent, 7 parts of a sweetener molecule, and 21 parts of a vanillin series neurosweetness molecule per 100 parts by weight.

[0150] The solvent is: 30 parts of propylene glycol, 30 parts of glycerol, 4 parts of ethylene glycol, 5 parts of propanol, and 3 parts of butanol.

[0151] The sweetener molecules are: 2 parts of neotame, 1 part of glucosyl stevioside, 1 part of neohesperidin dihydrochalcone, 1 part of hesperidin dihydrochalcone, 1 part of naringin dihydrochalcone, and 1 part of sucralose.

[0152] The vanillin series of neurosweet molecules are: 4 parts of ethyl vanillin, 4 parts of vanillin, 4 parts of isoeugenol, 4 parts of cadinene, 4 parts of eugenol, and 1 part of methyl salicylate.

[0153] The vanillin series electronic atomization liquid is filled into an electronic atomization device including a ceramic heating core for inhalation. A sensory evaluation is performed on the electronic atomization device filled with the electronic atomization liquids of Examples 1 to 6 and Comparative Examples 1 to 9.

[0154] The sensory evaluation method is as follows: 6 persons who have passed the sensory ability assessment are selected to form an evaluation team, and sweetness, burnt bitterness and other peculiar smells are used as evaluation indicators to conduct sensory evaluation on the electronic atomization device samples equipped with the electronic atomization liquid of Examples 1 to 6 and Comparative Examples 1 to 9. In order to eliminate the differences in electronic atomization devices, three parallel samples are arranged for each embodiment and comparative example. In order to eliminate the mutual influence between samples, the evaluators use 200mL of pure water to wash the mouth and throat before evaluating each sample, and remain silent until the sweetness of the previous sample is completely dissipated. The perceived sweetness is divided into 9 levels in order from low to high, and each is scored from 1 to 9 points. The scores of the 6 personnel are averaged to obtain a comprehensive sweetness score. The scoring criteria are shown in Table 1 below. When more than half of the 6 sensory personnel point out the presence of peculiar smell or burnt bitterness, the sample is deemed to have peculiar smell or burnt bitterness. The evaluation results are shown in Table 2 below.

[0155] Table 1 Sweetness rating criteria

[0156]

[0157] Table 2 Sensory evaluation results

[0158] Sample name Sweetness comprehensive score Odor or burnt bitter taste Example 1 8.15 none Example 2 8.33 none Example 3 8.67 none Example 4 4.98 none Example 5 8.97 none Example 6 7.03 none Comparative Example 1 4.16 none Comparative Example 2 8.29 Severe burnt bitter taste Comparative Example 3 4.13 none Comparative Example 4 8.36 Severe burnt bitter taste Comparative Example 5 4.22 none Comparative Example 6 7.78 Severe burnt bitter taste Comparative Example 7 1.35 none Comparative Example 8 7.22 Burnt bitter taste Comparative Example 9 6.89 Chemical smell

[0159] By analyzing the sensory evaluation results in Table 2, it can be seen that the electronic atomization liquids of Examples 1 to 6 have a high sweetness after atomization and inhalation, and no peculiar smell or burnt bitter taste is produced.

[0160] Comparative Examples 1, 3 and 5 are compared with the corresponding examples of Examples 1 to 3, respectively. The dosage of sweetener molecules is the same, but no vanillin series neurosweetness molecules are added. After atomization and inhalation, the sweetness felt is significantly reduced, and the sweetness is insufficient.

[0161] Compared with the corresponding embodiments of Examples 1 to 3, Comparative Examples 2, 4 and 6 respectively do not add vanillin series neurosweetness molecules, but increase the dosage of sweetener molecules by 2 times. Although the obtained electronic atomization liquid also has a high sweetness comparable to that of the corresponding embodiments, it will produce a severe burnt bitter taste during the inhalation process, which seriously affects the inhalation experience.

[0162] Compared with Example 4, the dosage of sweetener molecules in Comparative Example 7 is too low, and the sweetness of the electronic atomization liquid is not obvious. Compared with Example 5, the dosage of sweetener molecules in Comparative Example 8 is too high, and a burnt bitter taste will be produced during the inhalation process. Compared with Example 6, the dosage of vanillin series neurosweetness molecules in Comparative Example 9 is too high. Although it also has a relatively suitable sweetness, it will produce chemical odors and other peculiar smells during the inhalation process, affecting the taste.

[0163] The technical features of the above embodiments may be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0164] The above embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent application. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the inventive concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims.

Claims

1. A vanillin series electronic atomization liquid, characterized in that: According to parts by weight, it includes the following components: 0 to 99.9979 parts of solvent, 0.002 to 15 parts of sweetener molecules, and Vanillin series neurosweetness molecules 0.0001 to 20 parts; The vanillin series neurosweetness molecules include ethyl vanillin, vanillin, isoeugenol, cadinene and eugenol.

2. The vanillin series electronic atomization liquid according to claim 1, characterized in that: In every 100 parts by weight, the following components meet the following conditions: 74 to 82 parts of the solvent, 8 to 15 parts of the sweetener molecule, and The vanillin series neurosweetness molecules are 9 to 12 parts.

3. The vanillin series electronic atomization liquid according to claim 1, characterized in that: The vanillin series neurosweetness molecules also include 2-ethoxy-5-(1-propenyl)phenol, asarone, cubebene, terpinolene, myrcene, safrole, vetiverol, benzyl alcohol, methyl salicylate, γ-undecalactone, citral, ionone, dodecanal, octanal, jasmonate, tetradic acid, 2-hexanone, 2-heptanone, 1,8-cineole, cymene, nonanol, heptanol, terpinene, terpinene-4-ol, and 2-phenylethanol. One or more combinations thereof.

4. The vanillin series electronic atomization liquid according to any one of claims 1 to 3, characterized in that: The solvent includes one or more combinations of water, ethanol, ethylene glycol, propanol, propylene glycol, glycerol, butanol, butylene glycol, butanetriol, benzyl alcohol, triethyl citrate, triacetin and caprylic decanoic acid glyceride.

5. The vanillin series electronic atomization liquid according to any one of claims 1 to 3, characterized in that: The sweetener molecules include one or more combinations of neotame, advantame, sucralose, acesulfame potassium, glucosyl steviol glycosides, aspartame, hesperidin dihydrochalcone, neohesperidin dihydrochalcone and naringin dihydrochalcone.

6. The vanillin series electronic atomization liquid according to any one of claims 1 to 3, characterized in that: The components of the vanillin series electronic atomization liquid also include one or more of flavors, nicotine salts and cooling agents.

7. The vanillin series electronic atomization liquid according to claim 6, characterized in that: The flavor includes one or more combinations of strawberry flavor, watermelon flavor, lemon flavor, peach flavor, mango flavor, papaya flavor, orange flavor, grape flavor, lychee flavor, dragon fruit flavor, grapefruit flavor, apple flavor, banana flavor and coconut flavor.

8. The vanillin series electronic atomization liquid according to claim 6, characterized in that: The nicotine salt comprises a combination of one or more of nicotine benzoate, nicotine levulinate, nicotine tartrate, nicotine citrate, nicotine acetate and nicotine oxalate; and / or The cooling agent includes one or more combinations of WS-3, WS-5, WS-12, WS-14, WS-23, WS-25, WS-27, menthol, menthol ether and menthyl ester.

9. A method for preparing the vanillin series electronic atomization liquid according to any one of claims 1 to 8, characterized in that: The steps include: The components contained in the vanillin series electronic atomization liquid are mixed according to proportion.

10. An electronic atomization device, characterized in that: The invention comprises the vanillin series electronic atomization liquid as described in any one of claims 1 to 8.

Images